Risk Stratification of Patients with Extraprostatic Extension and Negative Lymph Nodes at Radical Prostatectomy: Identifying Optimal Candidates for Adjuvant Therapy

医学 前列腺切除术 生化复发 前列腺特异性抗原 前列腺癌 泌尿科 手术切缘 内科学 比例危险模型 阶段(地层学) 辅助治疗 肿瘤科 癌症 古生物学 生物
作者
Manuel S. Eisenberg,R. Jeffrey Karnes,Dharam Kaushik,Laureano J. Rangel,Eric J. Bergstralh,Stephen A. Boorjian
出处
期刊:The Journal of Urology [Lippincott Williams & Wilkins]
卷期号:190 (5): 1735-1741 被引量:15
标识
DOI:10.1016/j.juro.2013.05.053
摘要

Randomized trials demonstrate a benefit to adjuvant radiation therapy after radical prostatectomy in patients with pathologically locally advanced tumors. However, limited data exist on natural history, specifically in men with extraprostatic extension, and wide variability in outcomes has been reported. We evaluated long-term outcomes in patients with pT3aN0 disease and determined predictors of recurrence in these men.We evaluated 20,744 patients who underwent radical prostatectomy at our clinic between 1987 and 2011. Of these men 1,073 with pT3aN0 disease were identified who did not receive neoadjuvant or adjuvant therapy. Biochemical recurrence-free survival was estimated using the Kaplan-Meier method. Multivariate stepwise selection was used to develop a prognostic model for biochemical recurrence.Median followup after radical prostatectomy was 10.9 years, during which 449 patients experienced biochemical recurrence. On stepwise selection preoperative prostate specific antigen (HR 1.3, p=0.0003), clinical tumor stage (HR 1.2, p=0.001), pathological Gleason score (HR 1.9, p<0.0001), surgical margin status (HR 1.6, p<0.0001) and detectable first postoperative prostate specific antigen (HR 2.2, p<0.0001) were significantly associated with biochemical recurrence. Cumulative weighted scores of these variables were used to stratify patients into quintiles according to biochemical recurrence risk. The 15-year biochemical recurrence-free survival rate in the lowest to the highest risk group was 70%, 56%, 44%, 34% and 25%, respectively (p<0.0001). The c-index for this model was 0.69.We present a model to individualize the estimation of biochemical recurrence in men with pT3aN0 disease at radical prostatectomy. These data may be used for patient counseling, specifically in regard to risk stratification when discussing secondary therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Lynn完成签到,获得积分10
刚刚
仁和完成签到 ,获得积分10
刚刚
1秒前
Tina完成签到,获得积分10
1秒前
王哈哈完成签到,获得积分20
1秒前
3秒前
SciGPT应助科研通管家采纳,获得30
3秒前
quhayley应助科研通管家采纳,获得10
3秒前
香蕉觅云应助科研通管家采纳,获得10
3秒前
情怀应助科研通管家采纳,获得10
3秒前
丘比特应助科研通管家采纳,获得10
4秒前
赘婿应助科研通管家采纳,获得10
4秒前
4秒前
4秒前
SHAO应助科研通管家采纳,获得10
4秒前
Jasper应助科研通管家采纳,获得10
4秒前
March应助科研通管家采纳,获得10
4秒前
赘婿应助科研通管家采纳,获得10
4秒前
fd163c应助科研通管家采纳,获得10
4秒前
SYLH应助科研通管家采纳,获得20
4秒前
脑洞疼应助科研通管家采纳,获得10
4秒前
慕青应助科研通管家采纳,获得10
5秒前
无花果应助科研通管家采纳,获得10
5秒前
quhayley应助科研通管家采纳,获得10
5秒前
bkagyin应助科研通管家采纳,获得30
5秒前
搜集达人应助科研通管家采纳,获得10
5秒前
5秒前
传奇3应助科研通管家采纳,获得10
5秒前
Lucas应助科研通管家采纳,获得50
5秒前
5秒前
5秒前
6秒前
陈曦发布了新的文献求助10
6秒前
6秒前
6秒前
JamesPei应助科研通管家采纳,获得10
6秒前
6秒前
SYLH应助科研通管家采纳,获得20
6秒前
Atan完成签到,获得积分10
7秒前
Kevin发布了新的文献求助10
7秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988732
求助须知:如何正确求助?哪些是违规求助? 3531027
关于积分的说明 11252281
捐赠科研通 3269732
什么是DOI,文献DOI怎么找? 1804764
邀请新用户注册赠送积分活动 881869
科研通“疑难数据库(出版商)”最低求助积分说明 809021